JPH02290894A - Synthetic intermediate for glycolipid and its production - Google Patents
Synthetic intermediate for glycolipid and its productionInfo
- Publication number
- JPH02290894A JPH02290894A JP1112626A JP11262689A JPH02290894A JP H02290894 A JPH02290894 A JP H02290894A JP 1112626 A JP1112626 A JP 1112626A JP 11262689 A JP11262689 A JP 11262689A JP H02290894 A JPH02290894 A JP H02290894A
- Authority
- JP
- Japan
- Prior art keywords
- group
- reaction
- cer
- hydroxyl group
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229930186217 Glycolipid Natural products 0.000 title claims abstract description 6
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 title claims abstract description 4
- 238000004519 manufacturing process Methods 0.000 title description 2
- 150000001875 compounds Chemical class 0.000 claims abstract description 14
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 11
- 125000003342 alkenyl group Chemical group 0.000 claims abstract description 6
- 125000001033 ether group Chemical group 0.000 claims abstract description 5
- 125000001424 substituent group Chemical group 0.000 claims abstract description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 21
- 125000006239 protecting group Chemical group 0.000 claims description 9
- 229910052739 hydrogen Inorganic materials 0.000 claims description 8
- 239000000126 substance Substances 0.000 claims description 8
- 239000003153 chemical reaction reagent Substances 0.000 claims description 6
- 239000001257 hydrogen Substances 0.000 claims description 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 4
- 230000003213 activating effect Effects 0.000 claims description 4
- 238000003786 synthesis reaction Methods 0.000 claims description 4
- 230000015572 biosynthetic process Effects 0.000 claims description 3
- 150000003573 thiols Chemical class 0.000 claims 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 abstract description 4
- 239000007825 activation reagent Substances 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 description 25
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 18
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 17
- 239000000243 solution Substances 0.000 description 16
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 14
- 239000002808 molecular sieve Substances 0.000 description 12
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 12
- 239000000203 mixture Substances 0.000 description 11
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 8
- -1 lipid ceramides Chemical class 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- UDCDOJQOXWCCSD-UHFFFAOYSA-N N,N-dimethyl-N'-p-tolylsulfamide Chemical compound CN(C)S(=O)(=O)NC1=CC=C(C)C=C1 UDCDOJQOXWCCSD-UHFFFAOYSA-N 0.000 description 7
- 238000005481 NMR spectroscopy Methods 0.000 description 7
- 229940106189 ceramide Drugs 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- 239000000706 filtrate Substances 0.000 description 6
- 238000006206 glycosylation reaction Methods 0.000 description 6
- 239000000741 silica gel Substances 0.000 description 6
- 229910002027 silica gel Inorganic materials 0.000 description 6
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 5
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 5
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 5
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 4
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 4
- 229930182475 S-glycoside Natural products 0.000 description 4
- 125000004414 alkyl thio group Chemical group 0.000 description 4
- 150000001720 carbohydrates Chemical class 0.000 description 4
- 230000018044 dehydration Effects 0.000 description 4
- 238000006297 dehydration reaction Methods 0.000 description 4
- 125000003396 thiol group Chemical class [H]S* 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 239000000348 glycosyl donor Substances 0.000 description 3
- 230000013595 glycosylation Effects 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000010898 silica gel chromatography Methods 0.000 description 3
- 150000003569 thioglycosides Chemical class 0.000 description 3
- QWOJMRHUQHTCJG-UHFFFAOYSA-N CC([CH2-])=O Chemical compound CC([CH2-])=O QWOJMRHUQHTCJG-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 108010001496 Galectin 2 Proteins 0.000 description 2
- 108010001517 Galectin 3 Proteins 0.000 description 2
- 108010001515 Galectin 4 Proteins 0.000 description 2
- 102100021735 Galectin-2 Human genes 0.000 description 2
- 102100039558 Galectin-3 Human genes 0.000 description 2
- 102100039556 Galectin-4 Human genes 0.000 description 2
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 229910052786 argon Inorganic materials 0.000 description 2
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- 125000004705 ethylthio group Chemical group C(C)S* 0.000 description 2
- 150000002270 gangliosides Chemical class 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000000707 stereoselective effect Effects 0.000 description 2
- SFUVLEGIZGPPNN-UHFFFAOYSA-N (2-pyridin-2-ylacetyl) 2-pyridin-2-ylacetate Chemical compound C=1C=CC=NC=1CC(=O)OC(=O)CC1=CC=CC=N1 SFUVLEGIZGPPNN-UHFFFAOYSA-N 0.000 description 1
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
- YQTCQNIPQMJNTI-UHFFFAOYSA-N 2,2-dimethylpropan-1-one Chemical group CC(C)(C)[C]=O YQTCQNIPQMJNTI-UHFFFAOYSA-N 0.000 description 1
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 108010001498 Galectin 1 Proteins 0.000 description 1
- 102100021736 Galectin-1 Human genes 0.000 description 1
- 101000887167 Gallus gallus Gallinacin-6 Proteins 0.000 description 1
- 101000887235 Gallus gallus Gallinacin-9 Proteins 0.000 description 1
- 101000608766 Mus musculus Galectin-6 Proteins 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000012300 argon atmosphere Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 238000010531 catalytic reduction reaction Methods 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 125000001549 ceramide group Chemical group 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000012024 dehydrating agents Substances 0.000 description 1
- 238000010511 deprotection reaction Methods 0.000 description 1
- TXVLFCLSVCYBIV-UHFFFAOYSA-M dimethyl(methylsulfanyl)sulfanium;trifluoromethanesulfonate Chemical compound CS[S+](C)C.[O-]S(=O)(=O)C(F)(F)F TXVLFCLSVCYBIV-UHFFFAOYSA-M 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- CEIPQQODRKXDSB-UHFFFAOYSA-N ethyl 3-(6-hydroxynaphthalen-2-yl)-1H-indazole-5-carboximidate dihydrochloride Chemical compound Cl.Cl.C1=C(O)C=CC2=CC(C3=NNC4=CC=C(C=C43)C(=N)OCC)=CC=C21 CEIPQQODRKXDSB-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- PFJKOHUKELZMLE-VEUXDRLPSA-N ganglioside GM3 Chemical compound O[C@@H]1[C@@H](O)[C@H](OC[C@@H]([C@H](O)/C=C/CCCCCCCCCCCCC)NC(=O)CCCCCCCCCCCCC\C=C/CCCCCCCC)O[C@H](CO)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@]2(O[C@H]([C@H](NC(C)=O)[C@@H](O)C2)[C@H](O)[C@H](O)CO)C(O)=O)[C@@H](O)[C@@H](CO)O1 PFJKOHUKELZMLE-VEUXDRLPSA-N 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 150000002340 glycosyl compounds Chemical class 0.000 description 1
- 230000001279 glycosylating effect Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- WSBBSYJIJBSMBB-UHFFFAOYSA-N phenylselanyl trifluoromethanesulfonate Chemical compound FC(F)(F)S(=O)(=O)O[Se]C1=CC=CC=C1 WSBBSYJIJBSMBB-UHFFFAOYSA-N 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- QRUBYZBWAOOHSV-UHFFFAOYSA-M silver trifluoromethanesulfonate Chemical compound [Ag+].[O-]S(=O)(=O)C(F)(F)F QRUBYZBWAOOHSV-UHFFFAOYSA-M 0.000 description 1
- 125000003808 silyl group Chemical group [H][Si]([H])([H])[*] 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-O sulfonium Chemical compound [SH3+] RWSOTUBLDIXVET-UHFFFAOYSA-O 0.000 description 1
- 125000000037 tert-butyldiphenylsilyl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1[Si]([H])([*]C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- CZDYPVPMEAXLPK-UHFFFAOYSA-N tetramethylsilane Chemical compound C[Si](C)(C)C CZDYPVPMEAXLPK-UHFFFAOYSA-N 0.000 description 1
- 125000000011 thioglycoside group Chemical group 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Saccharide Compounds (AREA)
Abstract
Description
【発明の詳細な説明】
(従来の技術)
ガングリオシドは細胞膜に存在し、細胞の分化・発ガン
・免疫などその生理機能への関与は多岐にわたる。これ
らの機能解明に、ガングリオシドの化学合成の確立が切
望されて来た。[Detailed Description of the Invention] (Prior Art) Gangliosides exist in cell membranes, and are involved in a wide variety of physiological functions such as cell differentiation, carcinogenesis, and immunity. In order to elucidate these functions, there has been a strong desire to establish chemical synthesis of gangliosides.
従来からオリゴ糖鎮と脂質のセラミドとの高収率かつ立
体選択的なグリコシル化は重要な課題の一つである。従
来用いられてきたイミデート法(R,R.Schmid
t, R.Kager, Angew.Chemie,
,IntEd, Engl, 2 4巻,65頁.1
985年)、フッソ化糖法(T. Mukaiyama
et al.Chem, Lett,431頁、19
81年)は、いずれも反応収率が低く、反応段階が多い
といった問題点があり、高収率かつ高立体選択的な反応
の開発が望まれていた。High-yield and stereoselective glycosylation of oligosaccharide monomers and lipid ceramides has been one of the important issues. The conventionally used imidate method (R, R. Schmid
t, R. Kager, Angew. Chemie,
, IntEd, Engl, vol. 24, p. 65. 1
985), fluorinated sugar method (T. Mukaiyama)
et al. Chem, Lett, p. 431, 19
(1981) had problems such as low reaction yield and many reaction steps, and there was a desire to develop a reaction with high yield and high stereoselectivity.
(発明が解決しようとする課題)
従って、本発明は糖類と脂質のセラミドから簡易に、か
つ高収率、高立体選択的に糖脂質を製造できるグリコシ
ル化反応を提供することを目的とする。(Problems to be Solved by the Invention) Therefore, an object of the present invention is to provide a glycosylation reaction that can easily produce glycolipids from saccharides and lipid ceramides with high yield and high stereoselectivity.
(課題を解決するための手段)
本発明者は、活性化を行なわない場合においては酸性、
塩基性の両条件下に比較的安定なチオグリコシドをグリ
コシド供与体として用いると、適切な活性化によりアル
キルチオール基が極めて好適な脱離基として作用し、高
収率かつ高選択的にグリコシル化反応が進行することを
見出し、本発明を完成するに至った。(Means for Solving the Problems) The present inventor has proposed that when activation is not performed, acidic,
When thioglycosides, which are relatively stable under both basic conditions, are used as glycoside donors, the alkylthiol group acts as a very suitable leaving group upon appropriate activation, allowing glycosylation to occur in high yields and with high selectivity. They discovered that the reaction progresses and completed the present invention.
すなわち本発明は、下記の式(I)で示される化合物
とをチオール活性化試薬の存在下で反応させて、下記の
式(I[I)
R’
と、下記の式(I[)で示される化合物で示される化合
物を製造する方法
(式中、,R1は分技を有することのある低級アルキル
基を示し、Rt,R3及びR4はそれぞれ、保護基で保
護された水酸基若しくは遊離の水酸基を示し、RSは保
護基で保護された水酸基、tx離の水酸基、若しくは置
換基を有してもよい糖類の環上に結合したエーテル基を
示し、R6は水素、若しくは水酸基の保護基を示し、R
7はアルキル基、アルケニル基を示す)を提供するもの
である。That is, the present invention provides a compound represented by the following formula (I) that is reacted with a compound represented by the following formula (I) in the presence of a thiol activating reagent to form the following formula (I[I) R' and the following formula (I[)]. A method for producing a compound represented by a compound (in the formula, R1 represents a lower alkyl group that may have a fraction, and Rt, R3, and R4 each represent a hydroxyl group protected with a protecting group or a free hydroxyl group) RS represents a hydroxyl group protected with a protecting group, a tx-free hydroxyl group, or an ether group bonded to the ring of a saccharide which may have a substituent, R6 represents hydrogen or a protecting group for the hydroxyl group, R
7 represents an alkyl group or an alkenyl group).
Rl としてはメチル基、エチル基、n−プロビル基、
イソプロビル基、n−ブチル基、sec−ブチル基、t
ert−ブチル基等を例示できる。Rl is a methyl group, an ethyl group, an n-probyl group,
Isoprobyl group, n-butyl group, sec-butyl group, t
Examples include ert-butyl group.
RSとしては後述する水酸基保護基で保護された水酸基
、遊離の水酸基の他、例えば
等の、糖類の環上に結合したエーテル基を例示すること
ができる。Examples of RS include a hydroxyl group protected with a hydroxyl protecting group described below, a free hydroxyl group, and an ether group bonded to the ring of a saccharide, such as, for example.
R7としては01〜C,。のアルキル基、C,〜Cal
のアルケニル基が好ましく、特にCZ3のアルキル基が
好ましい。アルキル基、アルケニル基は直鎖でも分技し
ていてもよい。R7 is 01-C. alkyl group, C, ~Cal
The alkenyl group of is preferred, and the alkyl group of CZ3 is particularly preferred. The alkyl group and alkenyl group may be linear or branched.
以下に本発明の方法を用いた合成例を示す.α/β=5
7/4 3
α/β=65/35
前記で得られた化合物は脱保護することにより容易にガ
ングリオシドG M 3に導くことができる.虹は岡本
、近藤の報告( Bull. Chem. Soc.J
pn.,60巻.631頁,1987年)に記載された
方法により製造される。Examples of synthesis using the method of the present invention are shown below. α/β=5
7/4 3 α/β=65/35 The compound obtained above can be easily led to ganglioside GM 3 by deprotection. The rainbow is a report by Okamoto and Kondo (Bull. Chem. Soc. J
pn. , 60 volumes. 631, 1987).
尚、上記スキーム中Bnはベンジル基、TBDPSは3
級プチルジフエニルシリル基、Pivはピバロイル基、
H一一 は3級ブチル基、Bzはベンゾイル基、Acは
アセチル基、Phはフエニル基を示す。In the above scheme, Bn is a benzyl group, and TBDPS is 3
class butyldiphenylsilyl group, Piv is pivaloyl group,
H11 represents a tertiary butyl group, Bz represents a benzoyl group, Ac represents an acetyl group, and Ph represents a phenyl group.
本発明の方法は、アルキルチオ基で置換されたチオグリ
コシドと、脂質のセラミドを反応させてグリコシル化す
る方法において、グリコシル供与体となるチオグリコシ
ドをチオール活性化試薬を用いて活性化して縮合反応を
行うことに特徴がある.
グリコシル供与体となるチオグリコシドとしては、エチ
ルチオ(Et−S−)誘導体が好ましいが、他に3級ブ
チルチオ(+S−)、メチルチオ(CH.−S−) 、
イソブロビルチオ()一S−)等のアルキルチオ誘導体
も好適に使用できる.チオグリコシル体としては、ガラ
クトースのエチルチオ誘導体等、上記スキーム中の化合
物2、糖類も用いることができる.
これらのチオグリコシル体の水酸基を遊離の水酸基のま
まで本発明の方法のグリコシル化反応に用いてもよいが
、好ましくは、通常水酸基の保護に用いられる保護基、
例えばベンジル基、ベンゾイル基、アセチル基、シリル
基、アセトニドアリルカルボナート基等の保護基で保護
しておくことが望ましい.これらの保15は、該グリコ
シル化反応の終了後に通常の方法、例えば接触還元、酸
処理等の方法により容易に除去されて、目的のグリコシ
ル体を与える。The method of the present invention involves glycosylating a thioglycoside substituted with an alkylthio group by reacting a ceramide of a lipid, in which a thioglycoside serving as a glycosyl donor is activated using a thiol activating reagent to perform a condensation reaction. There are characteristics in what you do. As the thioglycoside serving as a glycosyl donor, ethylthio (Et-S-) derivatives are preferred, but other examples include tertiary butylthio (+S-), methylthio (CH.-S-),
Alkylthio derivatives such as isobrobylthio()-S-) can also be suitably used. As the thioglycosyl derivative, compound 2 in the above scheme and saccharides such as ethylthio derivatives of galactose can also be used. Although the hydroxyl groups of these thioglycosyl derivatives may be used as free hydroxyl groups in the glycosylation reaction of the method of the present invention, it is preferable to use a protecting group that is usually used for protecting hydroxyl groups,
For example, it is desirable to protect with a protecting group such as a benzyl group, benzoyl group, acetyl group, silyl group, or acetonide allyl carbonate group. After completion of the glycosylation reaction, these binders 15 are easily removed by conventional methods such as catalytic reduction and acid treatment to yield the desired glycosyl compound.
アルキルチオ基の活性化には、チオール活性化試薬であ
るDMTST (ジメチルメチルチオスルホニウムト
リフラート)、フェニルセレニルトリフラート等の試薬
を用いることができる。これらの試薬はチオール基を活
性化し、活性な脱離基とじて作用するスルホニウムイオ
ンを生じる.反応は通常−20゜C〜50゜Cの範囲で
、好まし《はN2、アルゴン等の不活性気流中で行う。To activate the alkylthio group, a thiol activating reagent such as DMTST (dimethylmethylthiosulfonium triflate) or phenylselenyl triflate can be used. These reagents activate the thiol group, producing a sulfonium ion that acts as an active leaving group. The reaction is usually carried out at a temperature in the range of -20°C to 50°C, preferably in an inert gas stream such as N2 or argon.
溶媒としては、無水溶媒が好ましく、例えば無水塩化メ
チレン、無水エチレンジクロリド、無水アセトニトリル
、ジメチルスルホキシド、ジメチルホルムアミド、二ト
ロメタン等を挙げることができる。反応時間は通常これ
らの条件下で1〜24時間である.無水化はモレキュラ
ーシーブスを用いる方法で行えばよい。The solvent is preferably an anhydrous solvent, such as anhydrous methylene chloride, anhydrous ethylene dichloride, anhydrous acetonitrile, dimethyl sulfoxide, dimethylformamide, ditromethane, and the like. The reaction time is usually 1 to 24 hours under these conditions. Dehydration may be carried out using a method using molecular sieves.
尚、上記の反応をモレキュラーシーブスの存在下に行う
ことが好ましい。モレキュラーシーブスは反応系中で脱
水剤として作用するので反応の収率向上、選択性向上に
有用である.例えばモレキュラーシーブスAW−3’0
0,4A,3A等を用いればよい.
上記の反応を行うにあたり、グリコシル供与体となるチ
オグリコシル体を、セラミド体に対し1モル〜3モル、
活性化試薬、例えばDMTSTを用いる場合にはセラミ
ド体に対して通常1モル〜3モ?を用いればよい。また
、モレキュラーシーブスは、セラミド体に対して10倍
重量で用いるのが好ましい。さらに、溶媒を溶質に対し
て30倍重量で用いるのがよい。Note that it is preferable to carry out the above reaction in the presence of molecular sieves. Molecular sieves act as a dehydrating agent in the reaction system and are useful for improving reaction yield and selectivity. For example, Molecular Thieves AW-3'0
0, 4A, 3A, etc. may be used. In carrying out the above reaction, the thioglycosyl form as a glycosyl donor is added at 1 mol to 3 mol based on the ceramide form.
When using an activation reagent such as DMTST, the amount is usually 1 to 3 moles per ceramide body. You can use Moreover, it is preferable to use the molecular sieves in an amount 10 times the weight of the ceramide body. Furthermore, it is preferable to use the solvent in an amount 30 times the weight of the solute.
反応の工程は、例えばチオグリコシル体とセラミド体を
溶媒、例えば無水塩化メチレン(Catlzで無水処理
したもの)に溶解し、モレキュラーシーブス(例えばモ
レキュラーシーブスAW−300 )加えて室温でアル
ゴン気流下に30〜100分程度撹拌する.この操作の
後、反応混合物を0゜Cに冷却してDMTSTを通常C
LtJ■溶液で滴下し、30分〜24時間程度の反応の
後に、好ましくはトリエチルアミン等のアミンで反応を
停止した後に、通常の後処理、例えばセライトを用いた
濾過の後に5%Nal{COi水溶液で洗浄し、無水N
atS04等を用いて脱水後溶媒を留去すれば良い。In the reaction step, for example, a thioglycosyl compound and a ceramide compound are dissolved in a solvent such as anhydrous methylene chloride (anhydrous treated with Catlz), and molecular sieves (for example, molecular sieves AW-300) are added thereto and the mixture is heated at room temperature for 30 minutes under an argon atmosphere. Stir for ~100 minutes. After this operation, the reaction mixture is cooled to 0°C and the DMTST is normally
After dropwise addition of LtJ solution and reaction for about 30 minutes to 24 hours, preferably after stopping the reaction with an amine such as triethylamine, after usual post-treatment, for example, filtration using Celite, 5% Nal{COi aqueous solution Wash with anhydrous N
The solvent may be distilled off after dehydration using atS04 or the like.
反応の収率は通常25%以上であり立体選択性は、例え
ばスキームに示す様にα/β=1〜0である.
(発明の効果)
本発明の方法により、脂質セラミドの高収率かつ高立体
選択的なグリコシル化が可能となった。The yield of the reaction is usually 25% or more, and the stereoselectivity is, for example, α/β=1 to 0, as shown in the scheme. (Effects of the Invention) The method of the present invention enables high-yield and highly stereoselective glycosylation of lipid ceramide.
本方法は、きわめて簡便な操作で目的とする糖脂質を高
収率で与える等の特徴を有する。This method has the characteristics of providing the desired glycolipid in high yield with an extremely simple operation.
(実施例)
以下に、本発明の方法を用いた糖脂質の合成を実施例と
して示すが本発明はこれらの実施例に限定されるもので
はない。(Example) The synthesis of glycolipids using the method of the present invention will be shown as an example below, but the present invention is not limited to these examples.
実施例中に用いた試薬、測定機器等を以下に示す。The reagents, measuring instruments, etc. used in the examples are shown below.
NMR:日本電子製(JEOL) GX−5 0 0C
DC j! *を溶媒とし、ケミカルシフトは内部基準
にテトラメチルシランを用いてδ値で示した。NMR: JEOL GX-5 0 0C
DC j! * was used as a solvent, and chemical shifts were expressed as δ values using tetramethylsilane as an internal standard.
シリカゲル:冨士ディビイソン化学 B W − 20
0シリカゲルプレート:
メルク社製(Merck)Kieselgel60 F
254 S
溶媒:CIIzCI!.zとCH2CNはCallzを
用いて蒸留後便用した。その他は半井化学薬品、和光純
薬工業の1級品をそのまま使用した。Silica gel: Fuji Davison Chemical B W-20
0 Silica gel plate: Merck Kieselgel 60 F
254S Solvent: CIIzCI! .. z and CH2CN were distilled using Callz and then evacuated. For the rest, first-class products from Hani Chemicals and Wako Pure Chemical Industries were used as they were.
尚、実施例中の化合物番号は、前記スキーム中の化合物
番号に対応したものである。In addition, the compound numbers in the examples correspond to the compound numbers in the above scheme.
実施例1
1 20■、2 14■をCI.C/! 20.4−
に溶解し、モレキュラーシーブスAW−300 13
0■を加え、Ar気流下に室温で100分間撹拌した.
そこヘ0. 2 3 M DMTST(CH.C ff
i !溶液)0.2dを0゜Cで撹拌しながら滴下し、
30分後反応液をセライトで濾過した。濾液を5%Na
HCO.水溶液で洗浄し、さらに無水NazSO.で脱
水した後、減圧下で濃縮乾固した。残査をシリカゲル力
ラムクロマト(ヘキサン/酢酸エチル=7/1)で分離
しα/β=5 7/4 3の混合物であった。混合物の
ままNMR測定を行った。Example 1 1 20■ and 2 14■ were treated with CI. C/! 20.4-
Dissolved in molecular sieves AW-300 13
0 ■ was added, and the mixture was stirred at room temperature for 100 minutes under an Ar flow.
There 0. 2 3 M DMTST (CH.C ff
i! Solution) 0.2d was added dropwise while stirring at 0°C,
After 30 minutes, the reaction solution was filtered through Celite. Add 5% Na to the filtrate.
H.C.O. Wash with anhydrous NazSO. After dehydration, the mixture was concentrated to dryness under reduced pressure. The residue was separated by silica gel column chromatography (hexane/ethyl acetate = 7/1) and was a mixture of α/β = 5 7/4 3. NMR measurements were performed on the mixture as it was.
性状:淡黄色油状
NMR
(α体由来のシグナル)
5.61(ppm) d lll Nil
J=8.5 (Hz)5.37
dd ill Cer−4 J=7.5.
15.25.18 td III
Cer−5 J=6.8, 15.24.77
d IH Glu−1’ J=4
.03.52 dd Ill Glu
−2’ J=4.0, 9.3(β体由来のシグナ
ル)
5.54(ppm) d IH Nl{
J・8.5 (lh)5.30 dd
1}I Cer−4 J=7.5 . 15.05
.03 td IH Cer−5 J=6
.8, 15.04.32 d ltl
Glu−1’ J=7.8実施例2
?解し、モレキュラーシーブスAW−300130■を
加え、Ar気流下、室温で30分間撹拌した。そこへ0
. 2 3 M DMTST(CH■C2.}容液)0
. 2 dを−23゜Cで撹拌しながら滴下し、−23
゜Cで反応させた.40分後Et,Nを10μ!加え反
応を止めた.反応液をセライトで濾過し濾液を減圧下で
濃縮乾固した。残査をシリカゲルプレート(ヘキサン/
酢酸エチル=5/3を3回展開)で.分離し、目的物8
.2■を得た(収率25%)。この化合物は α/β=
65/35の混合物であった.混合物のまま各種測定を
行った.
性状:淡黄色油状
NMR 3の各シグナルと同一であった。Properties: Pale yellow oily NMR (signal derived from alpha form) 5.61 (ppm) d lll Nil
J=8.5 (Hz)5.37
dd ill Cer-4 J=7.5.
15.25.18 td III
Cer-5 J=6.8, 15.24.77
d IH Glu-1' J=4
.. 03.52 dd Ill Glu
-2' J=4.0, 9.3 (signal derived from β body) 5.54 (ppm) d IH Nl{
J・8.5 (lh) 5.30 dd
1}I Cer-4 J=7.5. 15.05
.. 03 td IH Cer-5 J=6
.. 8, 15.04.32 dltl
Glu-1' J=7.8 Example 2? Then, Molecular Sieves AW-300130■ was added, and the mixture was stirred at room temperature for 30 minutes under an Ar flow. There 0
.. 2 3 M DMTST (CH■C2.} solution) 0
.. 2d was added dropwise while stirring at -23°C, and -23
The reaction was carried out at °C. After 40 minutes, add 10μ of Et and N! and stopped the reaction. The reaction solution was filtered through Celite, and the filtrate was concentrated to dryness under reduced pressure. Transfer the residue to a silica gel plate (hexane/
(Developed 3 times with ethyl acetate = 5/3). Separate and target object 8
.. 2■ was obtained (yield 25%). This compound is α/β=
It was a 65/35 mixture. Various measurements were performed on the mixture. Properties: Pale yellow oil. Same as NMR 3 signals.
但し、α、βの各シグナルの強度比が異なるものであっ
た。However, the intensity ratios of the α and β signals were different.
実施例3
6 15.0mgS1 23.8mgをCIItC
l z 0. 7 rrdlに溶解し、モレキュラー
シーブスAW−300130■を加え、Ar気流下、室
温で30分間撹拌した.そこへ0. 2 3 M DM
TST CLC l t溶液0. 2一を撹拌しながら
加え4時間後Et3Nを加え反応を止めた.反応液はセ
ライトで濾過し濾液を減圧下で濃縮乾固した。残査をシ
リカゲルカラムクロマト(ヘキサン/酢酸エチル=8/
1)で分離し、目的物lO.7■を得た(収率29%)
。Example 3 6 15.0mgS1 23.8mg as CIItC
l z 0. Molecular Sieves AW-300130■ was added to the solution, and the mixture was stirred at room temperature for 30 minutes under an Ar stream. There 0. 2 3 M DM
TST CLC l t solution 0. 21 was added with stirring, and after 4 hours, Et3N was added to stop the reaction. The reaction solution was filtered through Celite, and the filtrate was concentrated to dryness under reduced pressure. The residue was purified by silica gel column chromatography (hexane/ethyl acetate = 8/
1), the target object lO. 7■ was obtained (yield 29%)
.
性状:淡黄色油状
NMR
7.7−7.3(ppn+) cm 10N 芳香
族水素5.44
5.32−5.26
5.16−5.08
4.97
4.46
4.23
4.19
4.16−4.03
3.61
3.58
2.19−1.84
1.69
1.3−1.2
d III
tn 2H
m 2H
dd ill
d IH
dd 1}1
dd IH
m 3H
m IH
m IH
m21目
br 28
br 6411
1.01 s 911
0.90−0.86 br 6H
実施例4
?H J=8.5 (II■)Glu
−3’ Cer−4
Glu−4’ Cer−5
Glu−2’ J=7.6.9.4Glu−
1’ J=7.6
Cer−I J=9.4.3.7Cer−
3 J=7.2, 7.2Glu−6’
Cer−2
Glu−5’
Cer−1
COCI1■
Cer−6
COCL−Cz+IIn■ 、
C It = C II C II■一C+ lHz■
Si4CJ*
Cz+lLz−Clli 、C+ +lI■z−CH
zに溶解し、モレキュラーシーブスAW−300120
■を加え、A『気流下室温で1時間撹拌し?。そこへ0
. 2 5 M DMTST (Cll■C2■溶液)
0.7成を撹拌しながら加え、3時間後Et3Nを加え
反応を止めた。反応液はセライトで濾過し、濾液を減圧
下で濃縮乾固した。残査をシリカゲルプレート(ベンゼ
ン/ジエチルエーテル=lO/1を4回展開)で分離し
目的物4.5■を得た(収率l5%)。Properties: Pale yellow oil NMR 7.7-7.3 (ppn+) cm 10N Aromatic hydrogen 5.44 5.32-5.26 5.16-5.08 4.97 4.46 4.23 4.19 4.16-4.03 3.61 3.58 2.19-1.84 1.69 1.3-1.2 d III tn 2H m 2H dd ill d IH dd 1}1 dd IH m 3H m IH m IH m21st br 28 br 6411 1.01 s 911 0.90-0.86 br 6H Example 4? H J=8.5 (II ■) Glu
-3' Cer-4 Glu-4' Cer-5 Glu-2' J=7.6.9.4Glu-
1' J=7.6 Cer-I J=9.4.3.7Cer-
3 J=7.2, 7.2Glu-6'
Cer-2 Glu-5' Cer-1 COCI1■ Cer-6 COCL-Cz+IIn■, C It = C II C II■-C+ lHz■
Si4CJ* Cz+lLz-Clli, C+ +lI■z-CH
Dissolved in molecular sieves AW-300120
Add ■, and stir at room temperature under a stream of air for 1 hour. . There 0
.. 2 5 M DMTST (Cll■C2■ solution)
After 3 hours, Et3N was added to stop the reaction. The reaction solution was filtered through Celite, and the filtrate was concentrated to dryness under reduced pressure. The residue was separated on a silica gel plate (developed with benzene/diethyl ether=lO/1 4 times) to obtain 4.5 μl of the desired product (yield: 15%).
性状:淡黄色油状
NMR
8.10−7.30(ppm) m 3585.72
dd IH
5.40 dd il+5.21
d ll1
5.17−5. 12 rth 2H4.87
ta lo
4.59 d l}I
4.57 d lI1
4.47−4.44 br 2H4.31
dd IH
4.26−4.20 m 3114. 10−
4.01 m 3H芳香族水素
Glu−3’ J=9.0. 9.0Glu−2’
J=7.0. 7.8N旦 J・8.5
Gal−2’ , Cer−4
Cer−5 J=6.8, 15.0Glu−1’
J=7.8
Gal−1’ J=7.8
Gal−6’
Cer−I J=3.0. 9.0Glu−4’
.Gal−3’ ,Gal−4″Glu−6’ ,Ce
r−2+Cer−3?.76 m
lit Glu−5’3.73−3.68
rn 2H Glu−6’ .Gat−
5”3.47 dd Ill
Cer−I J=3.0. 9.751.5
7 s 3}1 アセト二ド1.34
−1.12 br 67H アセトニド,CH
=CI−CTo−C+ 1822、COC}l .−C
■114■
0.90−0.86 br 15H C++H
iz−CHz 、CzJaz−Cth、Si tcJ*
参考例l
試験管にスターラーバー、Na2HPO. ( 5
0 mg)、モレキュラーシーブス4A(80■)を入
れ、加熱乾燥後、上0(50mg、0. 0 8 1
mmof)、上上(55mg、0. 0 8 9 mm
offi)を加え、アルゴン置換したCII.CN
( 0. 3 d )を加えて室温撹拌し、30分後、
AgOTf (42mg、0. 1 6 1IIta
ol )のトルエン(0.3ae)溶液を加え、そのま
ま室温で撹拌し、8時間後40゜C (oil bat
h)で撹拌、2日後、60゜Cで撹拌して1日後酢酸エ
チルで希釈してセライト545で濾過し、酢酸エチルで
十分に洗った.濾液及び洗液を分液ロ一トに移し、Na
gS.0.水溶液、Na}ICO,水溶液、水で洗った
後、飽和食塩水で洗い、無水NazS04カラムで乾燥
後濃縮、乾固した.得られた残査(103mg)をカラ
ムクロマト(CH.C/!2 :アセトン=4 :
l)にかけて11を除いた。その他を再度力ラムクロマ
ト(アセトン:へキサン=1:2)にかけ、白色粉体と
して12(68mg、69%)を得た。Properties: Pale yellow oil NMR 8.10-7.30 (ppm) m 3585.72
dd IH 5.40 dd il+5.21
dll1 5.17-5. 12 rth 2H4.87
ta lo 4.59 d l}I 4.57 d lI1 4.47-4.44 br 2H4.31
dd IH 4.26-4.20 m 3114. 10-
4.01 m 3H aromatic hydrogen Glu-3' J=9.0. 9.0Glu-2'
J=7.0. 7.8N Dan J・8.5 Gal-2', Cer-4 Cer-5 J=6.8, 15.0Glu-1'
J=7.8 Gal-1' J=7.8 Gal-6' Cer-I J=3.0. 9.0Glu-4'
.. Gal-3', Gal-4''Glu-6', Ce
r-2+Cer-3? .. 76 m
lit Glu-5'3.73-3.68
rn2HGlu-6'. Gat-
5”3.47 dd Ill
Cer-I J=3.0. 9.751.5
7 s 3}1 acetonide 1.34
-1.12 br 67H Acetonide, CH
=CI-CTo-C+ 1822, COC}l. -C
■114■ 0.90-0.86 br 15H C++H
iz-CHz, CzJaz-Cth, SitcJ* Reference Example 1 A stirrer bar and Na2HPO. (5
0 mg), Molecular Sieves 4A (80■) was added, and after heating and drying, the top 0 (50 mg, 0.0 8 1
mmof), upper (55 mg, 0.089 mm
CII.offi) was added and replaced with argon. C.N.
(0.3 d) was added and stirred at room temperature, and after 30 minutes,
AgOTf (42mg, 0.1 6 1IIta
ol) in toluene (0.3ae) was added, the mixture was stirred at room temperature, and after 8 hours it was heated to 40°C (oil bat
After 2 days, the mixture was stirred at 60°C, and after 1 day it was diluted with ethyl acetate, filtered through Celite 545, and thoroughly washed with ethyl acetate. Transfer the filtrate and washing liquid to a separatory funnel, and add Na
gS. 0. Aqueous solution, Na}ICO, aqueous solution, washed with water, washed with saturated saline, dried with an anhydrous NazS04 column, and concentrated to dryness. The obtained residue (103 mg) was subjected to column chromatography (CH.C/!2:acetone=4:
1) and removed 11. The remaining residue was subjected to ram chromatography (acetone:hexane=1:2) again to obtain 12 (68 mg, 69%) as a white powder.
で示される構造中の水素をそれぞれH一口、H−0,H
一で示す。The hydrogens in the structure shown are H, H-0, H, respectively.
Shown in one.
IH NMR (δ,J in Hz, CDCj!z
)1.14−1.27 (30H,m,aPiv
& −SCH2CHl)1.93. 2.02. 2.
06. 2.09, 2.12 (3}1,5.−CH
3)3.21 (Ill, d,
3.44 (Ill. t,
3.47 (ill, d,
3.51 (ill. dt,
3.60 (1B,ddd,
3.70 (E. t,
3.72 (IL ddd,
3.91 (311, s,
4.02 (IH,dd,
4.07 (ill. t,
4.10 (ill, dd,
4.11 (IH, dd,
4.18 (1}1, dd,
4.21 (Ill, td,
4.27 (LH, dd,
4.29 (IH, s,
4.30 (IH,d,
4.32 (Ill, dd,
4.41 (ill. dd,
4.42 (LH,dd,
J・1.0,■−OH )
.r=9.5+ I+−4 )
J=11.0. n−tg )
J=1.0&7.5. 11−■)
J=1.5. 7.0 & 9.5,II−5
’)J・9,5, H−3 )
J=3.0, 4.0 & 8.0, H−■
0−CH3 )
J・7.0 & 12.5, H−(9))J=3.
0, If一■)
J・3.0&7.5, H一■)
J=7.0&12.5,I1−6 )
J・8.0 & 12.5, H−■)J=10.0
&11.O,I1−(5))J= 2.5 &l2.
5,u−[m )一〇H )
J=7.5. 1+−■)
J・4.0 &12.O.lI−■)J・1.5
&10.O.H−(6))J・9.5, I+−1
)
4.66 (IH, dd, J=2.0
&12.O, H−6 )4.87 (lft,
t , J=9.5 }1−2 )5.23 (
LH, dd, J=1.5 & 9.0.ll一
目)5.33 (IH, ddd, J=2.5,
7.0 & 9.0 H一1)5.36 (IH.
t, , J=11.O, H一阻)5.39 (
11{, d, , J=10.0. 酬)7.
13−7. 25 (5H, m, Ph )参考
例2
12、62mgをピリジンー無水酢酸溶液(2/1)
3rnlに溶かし、50℃で一晩撹拌した。反応溶液を
濃縮乾固後、その残渣をシリカゲル力ラムクロマト (
アセトン/n−ヘキサン=1/1)で分離し、目的物6
5mgを得た(収率、96%)。IH NMR (δ, J in Hz, CDCj!z
)1.14-1.27 (30H, m, aPiv
& -SCH2CHl)1.93. 2.02. 2.
06. 2.09, 2.12 (3}1,5.-CH
3) 3.21 (Ill, d, 3.44 (Ill. t, 3.47 (ill, d, 3.51 (ill. dt, 3.60 (1B, ddd, 3.70 (E. t, 3.72 (IL ddd, 3.91 (311, s, 4.02 (IH, dd, 4.07 (ill. t, 4.10 (ill, dd, 4.11 (IH, dd, 4.18) (1}1, dd, 4.21 (Ill, td, 4.27 (LH, dd, 4.29 (IH, s, 4.30 (IH, d, 4.32 (Ill, dd, 4.41) (ill. dd, 4.42 (LH, dd, J・1.0, ■-OH) .r=9.5+ I+-4) J=11.0.n-tg) J=1.0&7.5 .11-■) J=1.5. 7.0 & 9.5, II-5
') J・9,5, H-3) J=3.0, 4.0 & 8.0, H-■
0-CH3) J・7.0 & 12.5, H-(9)) J=3.
0, If-■) J・3.0&7.5, H-■) J=7.0&12.5, I1-6) J・8.0 & 12.5, H-■) J=10.0
&11. O, I1-(5)) J= 2.5 &l2.
5, u-[m)10H) J=7.5. 1+-■) J・4.0 &12. O. lI-■) J・1.5
&10. O. H-(6)) J・9.5, I+-1
) 4.66 (IH, dd, J=2.0
&12. O, H-6) 4.87 (lft,
t, J=9.5}1-2)5.23 (
LH, dd, J=1.5 & 9.0. ll glance) 5.33 (IH, ddd, J=2.5,
7.0 & 9.0 H-1) 5.36 (IH.
t, , J=11. O, H one stop) 5.39 (
11{, d, , J=10.0. compensation) 7.
13-7. 25 (5H, m, Ph) Reference Example 2 12, 62 mg was dissolved in pyridine-acetic anhydride solution (2/1)
The solution was dissolved in 3rnl and stirred at 50°C overnight. After concentrating the reaction solution to dryness, the residue was subjected to silica gel column chromatography (
Separate with acetone/n-hexane = 1/1) to obtain the target product 6.
5 mg was obtained (yield, 96%).
性状:白色粉末状
OAc
で示される構造中の水素をそれぞれH一口、H一〇、H
一で示す.
Ill NMR (δ ,J in llz,
CDCls)1.17−1.29 (30H,m
,aPiv & −SC82CH3)2.574.7
6 (211, va, −SCICH3 )3.
05 (IH, d, J.l2. I+−(3)
)3.57 (IH, dd, J・3.0&10.
5, o−[] )3.67 (IH, dd
d, J・2.0. 6.5 & 10.0.
11−5 )3.78 (18. t,
J=10.0, II−4 )3.90 (III,
dd, J・6.5&?.5, I1−■)3.
91 (3}1,
3.97 (lH.
4.00 (1}1.
4.05 (IH.
4.09 (IH.
4.16 (l}I,
4.40 (LH,
4.52 (IH.
4.63 (IH,
4.66 (l}l,
4.84 (IH.
4.93 (III,
5.10 (IH.
5.22 (IH.
5.23 (IH,
5.26 (1}1.
5.27 (l}l,
5.39 (1}1,
5.48 (l}l,
7.2−7.5
s, 0−CH3)
dd, J=7.5&lO.5. H−■)td,
J・10.0 &10.5, H−口》dd,
J=4.5&l2.5.H一謂)dd, J=6.
5&l2.0. }I−6)dd, J= 6.5
&10.5.H−■)dd, J=3.0&12
.5.8一謂)d, J=10.0, }l−1
)dd, J=2.0&l2.0, H−6 >
d. J=7.5. 8−■)
dd, J=3.5&lO.5, H−■)t ,
J=10.0 H−2 )dd, J=7.5
&10.5. 8一■》dd, J=10.0 &
12.0]一口)d, J=10.0, Inl
)d, J=3.5 . 8−■)
t, J=lO,O, H−3)dd, J=
3.0& 9.0. 8−口》ddd, J・a.
o 4.5 & 9.0. 8−El)(5H,
m, Ph )
3.69
3.59
3.57
3.53
3.05
1.32
1.01
0.88
?施例5
13 12.0mgをCIhCj2 Z−ClhCN
( 1 : 1 ) 0. 3成に溶解しモレキュラ
ーシーブス AW−300100■を加え、室温で15
分間撹拌した。そこへ、0.13M DMTST
Cll■C!■溶液0.14ml加え、さらに室温で1
5分間撹拌した。さらに1 9.5■をCHz(lz
o. 1 4dに溶解した溶液を撹拌しながら加え室
温で反応を行い、4時間後EtsNを加えて反応を止め
た。反応液をセライトで濾過し、濾液を11■0で洗浄
、有機層をNa,So.で脱水した後減圧下で濃縮乾固
した。残査をシリカゲルプレート(ヘキサン/アセトン
=3 : 2)で分取した後、再びシリカゲルプレート
(ベンゼン/酢酸エチル=1 : 1)で精製しほぼ純
品の13を2.5■得た(収率13χ)。Properties: White powder OAc The hydrogen in the structure shown is H, H10, and H, respectively.
Indicated by one. Ill NMR (δ , J in llz,
CDCls) 1.17-1.29 (30H, m
, aPiv & -SC82CH3) 2.574.7
6 (211, va, -SCICH3)3.
05 (IH, d, J.l2. I+-(3)
) 3.57 (IH, dd, J・3.0 & 10.
5, o-[] )3.67 (IH, dd
d, J・2.0. 6.5 & 10.0.
11-5) 3.78 (18.t,
J=10.0, II-4 )3.90 (III,
dd, J・6.5&? .. 5, I1-■)3.
91 (3}1, 3.97 (lH. 4.00 (1}1. 4.05 (IH. 4.09 (IH. 4.16 (l}I, 4.40 (LH, 4.52 ( IH. 4.63 (IH, 4.66 (l}l, 4.84 (IH. 4.93 (III, 5.10 (IH. 5.22 (IH. 5.23 (IH, 5.26) 1}1. 5.27 (l}l, 5.39 (1}1, 5.48 (l}l, 7.2-7.5 s, 0-CH3) dd, J=7.5&lO.5 .H-■)td,
J・10.0 &10.5, H-mouth》dd,
J=4.5&l2.5. H one so called) dd, J=6.
5&l2.0. }I-6) dd, J= 6.5
&10.5. H-■)dd, J=3.0&12
.. 5.8 1) d, J=10.0, }l-1
)dd, J=2.0&l2.0, H-6>
d. J=7.5. 8-■) dd, J=3.5&lO. 5, H-■)t,
J=10.0 H-2)dd, J=7.5
&10.5. 81■》dd, J=10.0 &
12.0] sip) d, J=10.0, Inl
)d, J=3.5. 8-■) t, J=lO, O, H-3) dd, J=
3.0 & 9.0. 8-mouth》ddd, J.a.
o 4.5 & 9.0. 8-El) (5H,
m, Ph) 3.69 3.59 3.57 3.53 3.05 1.32 1.01 0.88? Example 5 13 12.0 mg of CIhCj2 Z-ClhCN
(1:1) 0. Add Molecular Sieves AW-300100■ to
Stir for a minute. There, 0.13M DMTST
Cll■C! ■Add 0.14ml of the solution, and then add 1ml at room temperature.
Stir for 5 minutes. Further, convert 19.5■ to CHHz (lz
o. A solution dissolved in 14d was added with stirring to carry out the reaction at room temperature, and after 4 hours, EtsN was added to stop the reaction. The reaction solution was filtered through Celite, the filtrate was washed with 11.0, and the organic layer was washed with Na, So. After dehydration, the residue was concentrated to dryness under reduced pressure. The residue was collected on a silica gel plate (hexane/acetone = 3:2), and then purified again on a silica gel plate (benzene/ethyl acetate = 1:1) to obtain 2.5 μl of almost pure 13 (yield: rate 13χ).
性状:淡黄色油状
NMR
7.69−7.29(ppm) m 358 ar
omatic (Hz)5.81 td
01 Cer−5 J=7.0, 15.15
.62 dd IH Cer−4
J=15.1, 8.5Gal−5
Glu−5
Neu−6
Cer−1’
Neu−3
J=IO.8. 2.8
J=9.8,3.7
J=11.3
1.18
? II = C II− C II■−CllflL
lCOCHz−Ci+flj.
?i−t CaiL
CIIHz■−Ci!..COCHz−Cz1■4z−
CLIJ=6.3
5.50
5.4l
5.39
5.27
5.23
5.22
5.17
5. 10
4.94
4.87
4.84
4.65
4.56
4.45
4,39
4.21
4.06
4.05
4.00
3.78
Neu−8
Cer−Nil
Neu−7
Gal−4
Glu−3
Neu−4
Neu−Ntl
Gal−2
Cer−3
Glu−2
Gal−3
Gal−I
Glu−6
Glu−I
Neu−9
Cer−I
Glu−6’
Neu−9’
Neu−5
Glu−4
J・9.0. 5.1, 2.8
J・8.3
J・9.0, 2.8
J・3.8
J=9.5. 9.0
J・11.3, 10.O
J=9.8
J・9.9. 8.0
J・9.3, 8.5
J・9.5. 7.6
J=9.9.3.8
J=8.0
J=11.5,2.3
J・7.6
J・12.8. 2.8
J・9.8. 4.0
J・11.5. 6.5
J=12.8. 5.1
J・9.0, 9.0Properties: Pale yellow oil NMR 7.69-7.29 (ppm) m 358 ar
omatic (Hz)5.81 td
01 Cer-5 J=7.0, 15.15
.. 62dd IH Cer-4
J=15.1, 8.5Gal-5 Glu-5 Neu-6 Cer-1' Neu-3 J=IO. 8. 2.8 J=9.8, 3.7 J=11.3 1.18? II = C II- C II■-CllflL
lCOCHz-Ci+flj. ? it CaiL CIIHz■-Ci! .. .. COCHHz-Cz1■4z-
CLIJ=6.3 5.50 5.4l 5.39 5.27 5.23 5.22 5.17 5. 10 4.94 4.87 4.84 4.65 4.56 4.45 4,39 4.21 4.06 4.05 4.00 3.78 Neu-8 Cer-Nil Neu-7 Gal-4 Glu -3 Neu-4 Neu-Ntl Gal-2 Cer-3 Glu-2 Gal-3 Gal-I Glu-6 Glu-I Neu-9 Cer-I Glu-6'Neu-9' Neu-5 Glu-4 J・9.0. 5.1, 2.8 J・8.3 J・9.0, 2.8 J・3.8 J=9.5. 9.0 J・11.3, 10. O J=9.8 J・9.9. 8.0 J・9.3, 8.5 J・9.5. 7.6 J=9.9.3.8 J=8.0 J=11.5, 2.3 J・7.6 J・12.8. 2.8 J・9.8. 4.0 J・11.5. 6.5 J=12.8. 5.1 J・9.0, 9.0
Claims (2)
式(III) ▲数式、化学式、表等があります▼……(III) で示される化合物を製造する方法 (式中、R^1は分枝を有することのある低級アルキル
基を示し、R^2、R^3及びR^4はそれぞれ、保護
基で保護された水酸基若しくは遊離の水酸基を示し、R
^5は保護基で保護された水酸基、遊離の水酸基、若し
くは置換基を有してもよい糖類の環上に結合したエーテ
ル基を示し、R^6は水素、若しくは水酸基の保護基を
示し、R^7はアルキル基、アルケニル基を示す)。(1) A compound represented by the following formula (I) ▲There are mathematical formulas, chemical formulas, tables, etc.▼……(I) and a compound represented by the following formula (II) ▲There are mathematical formulas, chemical formulas, tables, etc.▼ ...(I) in the presence of a thiol activating reagent to produce a compound represented by the following formula (III) ▲Mathematical formula, chemical formula, table, etc.▼...(III) In the formula, R^1 represents a lower alkyl group that may have a branch, R^2, R^3 and R^4 each represent a hydroxyl group protected with a protecting group or a free hydroxyl group, and R
^5 represents a hydroxyl group protected by a protecting group, a free hydroxyl group, or an ether group bonded to the ring of a sugar that may have a substituent; R^6 represents hydrogen or a hydroxyl protecting group; R^7 represents an alkyl group or an alkenyl group).
基を示し、R^2、R^3及びR^4はそれぞれ、保護
基で保護された水酸基若しくは遊離の水酸基を示し、R
^5は保護基で保護された水酸基、遊離の水酸基、若し
くは置換基を有してもよい糖類の環上に結合したエーテ
ル基を示し、R^6は水素、若しくは水酸基の保護基を
示し、R^7はアルキル基、アルケニル基を示す)。(2) Glycolipid synthesis intermediate represented by the following formula (III) ▲Mathematical formulas, chemical formulas, tables, etc.▼...(III) (wherein R^1 is a lower alkyl group that may have a branch) , R^2, R^3 and R^4 each represent a hydroxyl group protected with a protecting group or a free hydroxyl group, and R
^5 represents a hydroxyl group protected by a protecting group, a free hydroxyl group, or an ether group bonded to the ring of a sugar that may have a substituent; R^6 represents hydrogen or a hydroxyl protecting group; R^7 represents an alkyl group or an alkenyl group).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1112626A JPH02290894A (en) | 1989-05-01 | 1989-05-01 | Synthetic intermediate for glycolipid and its production |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1112626A JPH02290894A (en) | 1989-05-01 | 1989-05-01 | Synthetic intermediate for glycolipid and its production |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH02290894A true JPH02290894A (en) | 1990-11-30 |
Family
ID=14591444
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP1112626A Pending JPH02290894A (en) | 1989-05-01 | 1989-05-01 | Synthetic intermediate for glycolipid and its production |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH02290894A (en) |
-
1989
- 1989-05-01 JP JP1112626A patent/JPH02290894A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Dan et al. | A convergent and stereocontrolled synthetic route to the core pentasaccharide structure of asparagine-linked glycoproteins | |
Pozsgay et al. | Synthetic oligosaccharides related to group B streptococcal polysaccharides. 3. Synthesis of oligosaccharides corresponding to the common polysaccharide antigen of group B streptococci | |
EP0064012B1 (en) | Disaccharides having units with a glucosamine and with a uronic-acid structure, their preparation and their biological application | |
Ogilvie et al. | Synthesis of oligoribonucleotides | |
US5830871A (en) | Inhibitors of E-, P- and L-selectin binding | |
WO1984001777A1 (en) | Method for carrying out the organic synthesis of oligosaccharides containing galactosamine-uronic acid patterns, new oligosaccharides obtained and biological applications thereof | |
Skrydstrup et al. | 1, 2‐cis‐C‐glycoside synthesis by samarium diiodide‐promoted radical cyclizations | |
FI95268B (en) | Process for Preparation of Glycoconjugates | |
JPS6399091A (en) | O-alpha-glycoside and its production | |
JPS6345293A (en) | Sialosylceramide compound and production thereof | |
Spohr et al. | Molecular recognition XI. The synthesis of extensively deoxygenated derivatives of the H-type 2 human blood group determinant and their binding by an anti-H-type 2 monoclonal antibody and the lectin 1 of Ulex europaeus | |
EP0728763B1 (en) | Ganglioside gm3 analog having sialic acid residue fluorinated at the 9-position and intermediate therefor | |
Li et al. | A facile synthesis of 1′-C-alkyl-α-disaccharides from 1-C-alkyl-hexopyranoses and methyl 1-C-methyl-hexopyranosides | |
KR900006213B1 (en) | Glycoliped containing n-glycolylyl-neuraminic acid and process for preparing the same | |
JPH02290894A (en) | Synthetic intermediate for glycolipid and its production | |
Binkley et al. | Participation by C-3 Substituents in Disaccharide Formation | |
Husain et al. | Synthesis of photoaffinity labeling derivatives of d-glucose and d-galactose | |
JPH02138291A (en) | Measuring method and measuring reagent for novel oligoglucoside derivative alpha- amylase | |
EP0342599A2 (en) | Polyacetyl oligosaccharide derivatives | |
Wong et al. | The synthesis of derivatives of lactosamine and cellobiosamine to serve as probes in studies of the combining site of the monoclonal anti-I Ma antibody | |
Manson et al. | Preparation of 2-methylene-. DELTA. 4-3-oxo steroids | |
US4301276A (en) | Synthesis of daunosamine hydrochloride and intermediates used in its preparation | |
Kadokawa et al. | New α-selective thermal glycosylation of acetyl-protected 2-acetamido-2-deoxy-β-d-glucopyranosyl diphenylphosphinate | |
US20040259814A1 (en) | Synthesis of solanum glycosides | |
JPH02292295A (en) | Preparation of etoposide |